FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9522211000001109: Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31078501000001118 Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
67048301000001116 Myocet 50mg powder and solvent for suspension for infusion vials (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Is a Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has excipient Lactose false Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has active ingredient Doxorubicin hydrochloride false Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has manufactured dose form Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Is a Myocet true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has specific active ingredient Doxorubicin hydrochloride false Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has active ingredient Doxorubicin liposome true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has dispensed dose form Powder and solvent for suspension for injection false Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has dispensed dose form Powder and solvent for suspension for infusion true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has manufactured dose form Powder and solvent for suspension for infusion true Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has specific active ingredient Doxorubicin hydrochloride liposomal pegylated true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) 2 vial Is pack of False Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) 2 vial Has AMP True Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start